EUCTR2013-000240-26-GB进行中（未招募）1 期
Cannabidiol as an add-on therapy in treatment-refractory psychotic disorders - CBD_ADD_I
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Aged 18-60 (inclusive) meeting DSM IV criteria for schizophrenia.
- •- Previous treatment with >=1 anti-psychotic at therapeutic doses for >= 5 weeks.
- •- Not currently in remission according to established criteria1.
- •- Willing to provide written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Pregnancy, lactation in women.
- •- Participants (both men and women) of child bearing potential who are not willing to use reliable contraceptive precautions for the treatment duration and for three months after discontinuation of therapy.
- •- Major physical illness.
- •- Mental retardation.
- •- Entry global Assessment of Functioning Scale (GAF) <20,
- •- Alcohol or drug dependence.
- •- Concomitant anti-depressant/anti-convulsant treatment for 2-months prior to study entry.
- •- Suicidal/homicidal traits.
- •- History of non-compliance.
研究者
相似试验
招募中
3 期
Evaluation of Cannabidiol effect in treatment of patients with Obsessive-Compulsive DisorderObsessive-compulsive disorderIRCT20210310050660N1Qazvin University of Medical Sciences40
招募中
2 期
Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH2024-518455-28-00Assistance Publique Hopitaux De Paris210
进行中（未招募）
1 期
Adjunctive cannabidiol therapy in patients with CDKL5 deficiency disorder. Interventional drug study on efficacy and safety with focus on seizure effectspatients with CDKL5MedDRA version: 20.0Level: PTClassification code 10015039Term: Epilepsy congenitalSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2021-001959-13-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE15
招募中
1 期
Cannabidiol as an Adjunct for the Treatment of Anorexia Nervosa (CAFTAN): An Open Label Pilot Trial with Extension in Young PeopleMental Health - Eating disordersAnorexia nervosaACTRN12622001306707niversity of Sydney30
进行中（未招募）
2 期
Cannabidiol for the treatment of patients at a high-risk of psychosisISRCTN10334895King’s College London and South London and Maudsley NHS Foundation Trust300